Next generation sequencing identifies 'interactome' signatures in relapsed and refractory metastatic colorectal cancer

Medicine and Dentistry

• Metastatic Colorectal Cancer 100%
• Patient 100%
• Combination Therapy 80%
• Next Generation Sequencing 80%
• Signal Transduction 40%
• Interactome 40%
• Drug Therapy 20%
• Irinotecan 20%
• Histology 20%
• Bevacizumab 20%
• Oxaliplatin 20%
• Oncogene 20%
• APC 20%
• Disease Course 20%
• Cetuximab 20%
• Drug Combination 20%
• Dependent Personality Disorder 20%
• Panitumumab 20%
• Colon Adenocarcinoma 20%
• Fluoropyrimidine 20%
• Fibroblast Growth Factor Receptor 20%
• Laboratory 20%
• Comprehension 20%
• Mitogen-Activated Protein Kinase 20%
• Clinical Decision Making 20%

Biochemistry, Genetics and Molecular Biology

• Mutation 60%
• Signal Transduction 40%
• KRAS 40%
• Interactome 40%
• Oncogene 20%
• Electric Potential 20%
• Mitogen-Activated Protein Kinase 20%
• Bioinformatics 20%
• Clinical Decision Making 20%
• Fibroblast Growth Factor Receptor 20%
• PDGFRA 20%
• Cetuximab 20%
• FBXW7 20%
• ROS1 20%
• Panitumumab 20%
• Bevacizumab 20%
• Comprehension 20%
• Colon 20%